[1] Smith RA.Manassaram-Baptlste D,Brooks DT, et al.Cancer screening in the United States.A review of current American Cancer Society guidelines and current issues in cancer screening[J].CA Cancer J Clin,2014,64(1):30-51. [2] 张颖聪. 肿瘤标志物检测方法研究进展[J].检验医学,2018,33(11):1036-1042. [3] 李策,聂彩辉,张力君,等.肿瘤标志物的应用及其筛选技术研究进展[J].药学进展,2014,38(1):1-13. [4] Gerdtsson AS,Wingren C,Persson H,et al. Plasma protein profiling in a stage defined pancreatic cancer cohort-implications for early diagnosis[J]. Mol Oncol, 2016, 10(8):1305-1316. [5] Wang WJ,Tao Z,Gu W,et al. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination[J]. Asian Pac J Cancer Prev,2013,14(40):4369-4371. [6] Jansen N,Coy JF. Diagnostic use of epitope detection in monocytes blood test for early detection of colon cancer metastasis[J]. Future Oncol,2013,9(4):605-609. [7] Chang Y, Xu J, Zhang Q. Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer[J]. Oncol Lett, 2017, 14(4):4043-4052. [8] Nakagawa M, Karashima T, Kamada M, et al. Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer[J]. Biomark Res, 2017, 5:29. [9] 焦鑫,何思春,万绍恒,等. 肿瘤标志物在肺癌诊断、预后预测中的临床价值[J]. 中国老年学杂志,2019,2(39):811-814. [10] Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma[J]. Hepatology,2018,67(1):358-380. [11] Grah JJ,Katalinic D,Juretic A,et al.Clinical significance of immunohistochemical expression of cancer/testis tumor-as-sociated antigens(MAGE-A1,MAGE-A3/4,NY-ESO-1) in patients with non-small cell lung cancer[J].Tumori,2014,100(1):60-68. [12] 巩晓瑞,马锐. 肿瘤标志物的临床意义及研究进展[J]. 医学与哲学,2018,39(12B):48-52. [13] Shintani T,Matsuo Y,Iizuka Y,et al. Prognostic significance of serum CEA for non-small cell lung cancer patients receiving stereotactic body radiotherapy[J]. Anticancer Res,2017,37(9):5161. [14] 赵雯.化学发光免疫法在肿瘤生物标志物检验中的应用意义[J].中外医疗,2019,38(36):194-195,198. [15] Lin J,Chu P,Wei Z. A new dual immunoassay for tumor markers based on chemiluminescence signal amplification by magnetic mesoporous silica and enzyme modified gold nanoparticles[J].Analsci,2012,28(1):21-25. [16] 佟彤,冯玥,陈田. 郑州地区45～60岁人群肿瘤标志物筛查及结果分析[J]. 实用预防医学,2020,27(1):116-119. [17] Kokudo N,Hasegawa K,Akahane M,et al.Evidence—based clinical practice guidelines for hepatocellular carcinoma:the Japan Society of Hepatology 2013 update(3rd JSH—HCC guidelines)[J].Hepatol Res,2015,45(2):123-127.
2021, Vol. 28 
